Addressing Clinical Trial Accrual of Minority Patients With Donna Catamero, NP

At the recent International Myeloma Society (IMS) Annual Meeting, Donna Catamero, NP, Associate Director of Myeloma Translational Research at Mount Sinai Hospital, presented her abstract regarding increasing clinical trial accrual of minority patients. In this interview, Ms. Catamero discusses her presentation, the disproportionate burden that minority patients experience, and why she believes the health care team should take action to create an equal space for everyone in the clinic.